Bone loss caused by iron overload in a murine model: importance of oxidative stress

被引:353
作者
Tsay, Jaime [1 ]
Yang, Zheiwei [1 ]
Ross, F. Patrick [2 ]
Cunningham-Rundles, Susanna [1 ]
Lin, Hong [1 ]
Coleman, Rhima [2 ]
Mayer-Kuckuk, Philipp [2 ]
Doty, Stephen B. [2 ]
Grady, Robert W. [1 ]
Giardina, Patricia J. [1 ]
Boskey, Adele L. [2 ]
Vogiatzi, Maria G. [1 ]
机构
[1] Weill Cornell Med Coll, Dept Pediat, New York, NY 10065 USA
[2] Hosp Special Surg, Div Res, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
BETA-THALASSEMIA MAJOR; SERUM FERRITIN; SPECTROSCOPIC CHARACTERIZATION; DISEASE; DEFICIENCY; ADULTS; OSTEOCLASTOGENESIS; ANTIOXIDANTS; INFLAMMATION; METABOLISM;
D O I
10.1182/blood-2009-12-260083
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Osteoporosis is a frequent problem in disorders characterized by iron overload, such as the thalassemias and hereditary hemochromatosis. The exact role of iron in the development of osteoporosis in these disorders is not established. To define the effect of iron excess in bone, we generated an iron-overloaded mouse by injecting iron dextran at 2 doses into C57/BL6 mice for 2 months. Compared with the placebo group, iron-overloaded mice exhibited dose-dependent increased tissue iron content, changes in bone composition, and trabecular and cortical thinning of bone accompanied by increased bone resorption. Iron-overloaded mice had increased reactive oxygen species and elevated serum tumor necrosis factor-alpha and interleukin-6 concentrations that correlated with severity of iron overload. Treatment of iron-overloaded mice with the antioxidant N-acetyl-L-cysteine prevented the development of trabecular but not cortical bone abnormalities. This is the first study to demonstrate that iron overload in mice results in increased bone resorption and oxidative stress, leading to changes in bone microarchitecture and material properties and thus bone loss. (Blood. 2010;116(14):2582-2589)
引用
收藏
页码:2582 / 2589
页数:8
相关论文
共 50 条
[1]
Hepatic iron concentration and total body iron stores in thalassemia major. [J].
Angelucci, E ;
Brittenham, GM ;
McLaren, CE ;
Ripalti, M ;
Baronciani, D ;
Giardini, C ;
Galimberti, M ;
Polchi, P ;
Lucarelli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (05) :327-331
[2]
N-Acetylcysteine -: a safe antidote for cysteine/glutathione deficiency [J].
Atkuri, Kondala R. ;
Mantovani, John J. ;
Herzenberg, Leonard A. ;
Herzenberg, Leonore A. .
CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (04) :355-359
[3]
Intravenous iron [J].
Auerbach, Michael ;
Rodgers, George M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :93-94
[4]
Recycling Iron in Normal and Pathological States [J].
Beaumont, Carole ;
Delaby, Constance .
SEMINARS IN HEMATOLOGY, 2009, 46 (04) :328-338
[5]
BOSKEY AL, 1992, CELL MATER, V2, P209
[6]
Infrared spectroscopic characterization of mineralized tissues [J].
Boskey, AL ;
Mendelsohn, R .
VIBRATIONAL SPECTROSCOPY, 2005, 38 (1-2) :107-114
[7]
HEPATIC IRON STORES AND PLASMA FERRITIN CONCENTRATION IN PATIENTS WITH SICKLE-CELL-ANEMIA AND THALASSEMIA MAJOR [J].
BRITTENHAM, GM ;
COHEN, AR ;
MCLAREN, CE ;
MARTIN, MB ;
GRIFFITH, PM ;
NIENHUIS, AW ;
YOUNG, NS ;
ALLEN, CJ ;
FARRELL, DE ;
HARRIS, JW .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 42 (01) :81-85
[8]
EFFECT OF ASCORBIC-ACID DEFICIENCY ON SERUM FERRITIN CONCENTRATION IN PATIENTS WITH BETA-THALASSEMIA MAJOR AND IRON OVERLOAD [J].
CHAPMAN, RWG ;
HUSSAIN, MAM ;
GORMAN, A ;
LAULICHT, M ;
POLITIS, D ;
FLYNN, DM ;
SHERLOCK, S ;
HOFFBRAND, AV .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (05) :487-491
[9]
Chevion M, 2000, FREE RADICAL RES, V33, pS99
[10]
Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine [J].
DeSanctis, V ;
Pinamonti, A ;
DiPalma, A ;
Sprocati, M ;
Atti, G ;
Gamberini, MR ;
Vullo, C .
EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (05) :368-372